Patents by Inventor Marcus Frohme

Marcus Frohme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONVERTIBLE ADAPTERS
    Publication number: 20190249239
    Abstract: The invention relates to a method and a kit comprising single or at least partially double-stranded adapters comprising sequences with base modifications that are ligated to nucleic acid fragments and converted to generate asymmetric ends for specific recognition. The method is based on two main sequence conversion mechanisms, a direct conversion of specific bases and an indirect conversion by copying, wherein both mechanisms may be combined.
    Type: Application
    Filed: September 12, 2017
    Publication date: August 15, 2019
    Applicant: TECHNISCHE HOCHSCHULE WILDAU
    Inventors: Jörn GLÖKLER, Marcus FROHME
  • INHIBITION OF TRISTETRAPROLINE FOR PROTECTION OF THE HEART FROM CARDIAC INJURIES
    Publication number: 20090104182
    Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF ? production. The invention further relates to assays for the identification of an individual at increased risk for or suffering front such conditions and to methods of screening compounds for their ability to enhance TNF ? biosynthesis.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 23, 2009
    Inventors: Franz-Werner KLUXEN, Bernd HENTSCH, Thomas EHRING, Marian BRANDLE, Jorg HOHEISEL, Marcus FROHME, Dimitri ZUBAKOV
  • Larynx carcinoma-associated protein larcap-1
    Publication number: 20060252157
    Abstract: Larynx carcinoma associated protein-1 (LarCAP-1) polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing LatCAP-1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: February 12, 2001
    Publication date: November 9, 2006
    Inventors: Klaus Ducker, Bernd Hentsch, Marcus Frohme, Jorg Hoheisel
  • New lipid binding protein 1
    Publication number: 20060216750
    Abstract: New Lipid Binding Protein 1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing New Lipid Binding Protein 1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: December 22, 2005
    Publication date: September 28, 2006
    Inventors: Matthias Grell, Klaus Ducker, Jorg Hoheisel, Marcus Frohme
  • Human extracellular signal regulated kinases
    Patent number: 7037699
    Abstract: ERK-7 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ERK-7 polypeptides and polynucleotides in diagnostic assays.
    Type: Grant
    Filed: March 7, 2001
    Date of Patent: May 2, 2006
    Assignee: Merck Patent GmbH
    Inventors: Simon Goodman, Burkhard Scharm, Marcus Frohme, Joerg Hoheisel
  • Lipid binding protein 1
    Publication number: 20050107592
    Abstract: New Lipid Binding Protein 1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing New Lipid Binding Protein 1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: April 4, 2001
    Publication date: May 19, 2005
    Inventors: Matthias Grell, Klaus Ducker, Jorg Hoheisel, Marcus Frohme
  • Inhibition of tristetraproline for protection of the heart from cardiac injuries
    Publication number: 20050084860
    Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF ? production. The invention further relates to assays for the identification of an individual at increased risk for or suffering from such conditions and to methods of screening compounds for their ability to enhance TNF ? biosysthesis.
    Type: Application
    Filed: November 30, 2002
    Publication date: April 21, 2005
    Inventors: Franz-Werner Kluxen, Bernd Hentsch, Thomas Ehring, Marian Brandle, Jorg Hoheisel, Marcus Frohme, Dimitri Zubakov
  • F-box containing protein
    Publication number: 20030143654
    Abstract: New F-Box Containing Protein-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing New F-Box Containing Protein-1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 31, 2003
    Inventors: Matthias Grell, Klaus Ducker, Marcus Frohme, Jorg Hoheisel
  • Gtpase-activating protein 1
    Publication number: 20030096282
    Abstract: New GTPase-Activating Protein 1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing New GTPase-Activating Protein 1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: October 30, 2002
    Publication date: May 22, 2003
    Inventors: Christian Sirrenberg, Bjorn Hock, Jorg Dietrich Hoheisel, Marcus Frohme